These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Development of highly potent and selective dynorphin A analogues as new medicines. Lung FD, Chen CH, Liu JH. J Pept Res; 2005 Nov 14; 66(5):263-76. PubMed ID: 16218994 [Abstract] [Full Text] [Related]
17. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2. Lung FD, Collins N, Stropova D, Davis P, Yamamura HI, Porreca F, Hruby VJ. J Med Chem; 1996 Mar 01; 39(5):1136-41. PubMed ID: 8676350 [Abstract] [Full Text] [Related]
18. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4. Cheng LL, Stoev S, Manning M, Derick S, Pena A, Mimoun MB, Guillon G. J Med Chem; 2004 Apr 22; 47(9):2375-88. PubMed ID: 15084136 [Abstract] [Full Text] [Related]
19. Structure-activity relationships of dynorphin analogs substituted in positions 2 and 3. Schlechtingen G, DeHaven RN, Daubert JD, Cassel J, Goodman M. Biopolymers; 2003 Apr 22; 71(1):71-6. PubMed ID: 12712501 [Abstract] [Full Text] [Related]
20. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism. Balboni G, Salvadori S, Guerrini R, Negri L, Giannini E, Bryant SD, Jinsmaa Y, Lazarus LH. J Med Chem; 2004 Jul 29; 47(16):4066-71. PubMed ID: 15267245 [Abstract] [Full Text] [Related] Page: [Next] [New Search]